News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Michael Abrams, Numerof & Associates

Advertisement

Managing partner at Numerof & Associates.

Articles by Michael Abrams, Numerof & Associates

Key Elements for Success in Pharma M&A Integration

ByMichael Abrams, Numerof & Associates
October 1st 2024

How can buyers maximize the value of their acquisitions?

Pharmacy Deserts are Becoming a National Problem

ByMichael Abrams, Numerof & Associates
August 12th 2024

A lack of access could shut out patients in need of maintenance drugs for complex conditions.

Bringing value to healthcare: practical steps for getting to a market-based model

ByRita Numerof, PhD,Michael Abrams, Numerof & Associates
March 9th 2016

A new, market-driven model of drug development and commercialization is appearing*

Advertisement

Latest Updated Articles

  • Bringing value to healthcare: practical steps for getting to a market-based model
    Bringing value to healthcare: practical steps for getting to a market-based model

    Published: March 9th 2016 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

United States Delays Tariffs on Singapore’s Pharma Exports Amid Ongoing Trade Negotiations

2

Novo Nordisk’s Bloomington Plant Receives FDA OAI Designation Following Contamination and Compliance Issues

3

Pharma Pulse: Kaiser Permanente Strike Escalates, Takeda Partners with Nabla Bio, and FDA Flags Novo Nordisk Bloomington Site

4

From Volume to Value: Rethinking What Drives Better Health Outcomes

5

How Healthcare Organizations Can Balance Federal and State AI Regulations

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us